Indication :Â
Epirubicin HCl administered as a single agent has shown to produce regression in a broad spectrum of tumours including mammary carcinoma, malignant lymphomas, soft tissue sarcomas and gastric cancer. Prelimenary findings indicate that the drug has produced some anti tumor activity in malignant melanoma and in advanced colorectal carcinoma. Given in combination with other antiblastic drugs, Epirubicin HCl has also induced a therapeutic response in lung and ovarian cancer.
Compositions :
Each mL Epirubicin hydrochloride 2 mg
Storage Condition :
Store in refrigerator (2 – 8°C), protect from light. Keep medicine out of reach of children.
